Furthermore, we used metformin, a compound that we had shown previously to interfere with the MID1 complex and inactivate translation of MID1-target mRNAs7,14,15, for a chronic treatment of an AD mouse model at a progressed state of disease. This evidence concerns the gene MID1 and Alzheimer disease.